Showing results (181-190 of 364) with videos related to
Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsV Gandhi, W Plunkett, S Weller, et al.Cancer Chemotherapy and Pharmacology|December 1, 2006
Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemiaPatrick A Thompson, Daryl J Murry, Gary L Rosner, et al.International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung CancerKristin J Redmond, Russell K Hales, Heather Anderson-Keightly, et al.Blood|September 13, 2003
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemiaShinji Kishi, Wenjian Yang, Benoit Boureau, et al.Oncotarget|April 29, 2020
Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancerIndu Kohaar, Qiyuan Li, Yongmei Chen, et al.The Journal of Urology|January 25, 2019
Impact of Subsequent Biopsies on Comprehensive Health Related Quality of Life in Patients with and without Prostate CancerJohn F Burns, Lauren M Hurwitz, Katherine E Levie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565A P Venook, M J Egorin, G L Rosner, et al.Urologic Oncology|April 16, 2017
Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancerKai H Hammerich, Timothy F Donahue, Inger L Rosner, et al.Science (New York, N.Y.)|May 6, 1988
Translocation and rearrangement of myeloperoxidase gene in acute promyelocytic leukemiaS C Weil, G L Rosner, M S Reid, et al.Cancer|April 15, 2011
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagyMin-Yu Chen, Warren S-L Liao, Zhen Lu, et al.Pageof 37